Tamara PfaffHead of Preclinical Development at AiCuris Anti-infective Cures AGSpeaker
Profile
Dr. Tamara Pfaff (Vice President Preclinical Development; Anti-infective Cures AG)
Tamara joined AiCuris in 2010 as Head of Preclinical Drug Safety and steadily increased her responsibilities. She became Senior Director in 2018 and was responsible for all preclinical safety aspects of the AiCuris portfolio. In 2020, she became Head of Preclinical Development. Tamara started her industrial career in 2004 as Head of Laboratory Preclinical Development in the Global Research and Development department of Gruenenthal GmbH and was promoted International Preclinical Project Leader in 2009. She is veterinarian by training and in addition helds a master´s degree in applied toxicology. Tamara is certified pathologist and recognized as a Eurotox-registered toxicologist. She studied at the Universities of Gießen and Surrey, Guildford (UK).
Agenda Sessions
AIC468 – A Novel Antisense Oligonucleotide in Clinical Development for Treatment of BKV Infections
, 16:15View Session